These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1149791)

  • 1. Central inhibitory effect of alpha-methyldopa on blood pressure, heart rate and body temperature of renal hypertensive rats.
    Nijkamp FP; Ezer J; De Jong W
    Eur J Pharmacol; 1975 Apr; 31(2):243-9. PubMed ID: 1149791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chlorpromazine interactions with guanethidine and alpha-methyldopa: effects on arterial pressure control and heart rate in renovascular hypertensive rats.
    Rankin GO; Watkins BE; Sawutz DG
    Arch Int Pharmacodyn Ther; 1982 Nov; 260(1):130-40. PubMed ID: 7165417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Centrally induced hypotension by alpha-methyldopa and alpha-methylnoradrenaline in normotensive and renal hypertensive rats.
    Nijkamp FP; De Jong W
    Prog Brain Res; 1977; 47():349-68. PubMed ID: 337354
    [No Abstract]   [Full Text] [Related]  

  • 4. The mechanism of the antihypertensive action of -methyldopa in hypertensive rats.
    Day MD; Roach AG; Whiting RL
    Eur J Pharmacol; 1973 Mar; 21(3):271-80. PubMed ID: 4196583
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical and cardiovascular effects of alpha methyldopa in combination with decarboxylase inhibitors.
    Kersting F; Reid JL; Dollery CT
    Clin Pharmacol Ther; 1977 May; 21(5):547-55. PubMed ID: 322921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of action of methyldopa in the rat. Role of 3-O-methylated metabolites.
    Zavisca FG; Breau AP; Wurtman RJ
    Circ Res; 1979 Nov; 45(5):684-90. PubMed ID: 487531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential blood pressure responses to intracisternal clonidine, alpha-methyldopa, and 6-hydroxydopamine in conscious normotensive and spontaneously hypertensive rats.
    Head GA; de Jong W
    J Cardiovasc Pharmacol; 1986; 8(4):735-42. PubMed ID: 2427812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Site of action of methyldopa in lowering the blood pressure in man.
    Kersting F; Reid JL; Dollery CT
    Clin Exp Pharmacol Physiol Suppl; 1978; 4():11-5. PubMed ID: 277299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of reserpine, guanethidine and methyldopa on cardiac output and its distribution.
    Kisin I; Yuzhakov S
    Eur J Pharmacol; 1976 Feb; 35(2):253-60. PubMed ID: 1248504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. beta-endorphin acting on the brainstem is involved in the antihypertensive action of clonidine and alpha-methyldopa in rats.
    Ramirez-Gonzalez MD; Tchakarov L; Mosqueda Garcia R; Kunos G
    Circ Res; 1983 Aug; 53(2):150-7. PubMed ID: 6309428
    [No Abstract]   [Full Text] [Related]  

  • 11. Mechanism of the hypotensive action of methyldopa in normal and immunosympathectomized rats.
    Ayitey-Smith E; Varma DR
    Br J Pharmacol; 1970 Oct; 40(2):186-93. PubMed ID: 5492891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On the mechanism of L-dopa-induced postural hypotension in the cat.
    Dhasmana KM; Spilker BA
    Br J Pharmacol; 1973 Mar; 47(3):437-51. PubMed ID: 4147189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of the tachycardia following systemic alpha-methyldopa administration in conscious rats.
    van der Maas ML; Head GA; de Jong W
    J Cardiovasc Pharmacol; 1986; 8(5):1014-9. PubMed ID: 2429074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of central and peripheral mechanisms in the action of alpha-methyldopa on blood pressure and renin secretion.
    Frankel RJ; Reid IA; Ganong WF
    J Pharmacol Exp Ther; 1977 May; 201(2):400-5. PubMed ID: 323462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Relationship between the antihypertensive activity of methyldopa and the appearance of its metabolites in the heart and brain of the hypertensive rat].
    Cohen Y; Wepierre J; Jacquot C; Rapin J
    Arch Int Pharmacodyn Ther; 1974 Feb; 207(2):348-60. PubMed ID: 4827419
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of the antihypertensive drugs alpha-methyldopa and hydralazine on the performance of spontaneously hypertensive rats in the elevated plus-maze.
    Rosa WC; Oliveira GM; Nakamura-Palacios EM
    Braz J Med Biol Res; 1994 Jan; 27(1):55-9. PubMed ID: 8173530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Possible role of an endogenous opiate in the cardiovascular effects of central alpha adrenoceptor stimulation in spontaneously hypertensive rats.
    Farsang C; Ramirez-Gonzalez MD; Mucci L; Kunos G
    J Pharmacol Exp Ther; 1980 Jul; 214(1):203-8. PubMed ID: 6248627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On the role of alpha-methyldopamine in the antihypertensive effect of alpha-methyldopa.
    Waldmeier P; Hedwal PR; Maître L
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 289(3):303-14. PubMed ID: 169487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Further evidence for a central hypotensive action of alpha-methyldopa in both the rat and cat.
    Finch L; Haeusler G
    Br J Pharmacol; 1973 Feb; 47(2):217-28. PubMed ID: 4722038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central and peripheral cardiovascular effects of alpha-methylepinephrine.
    Tung CS; Goldberg MR; Hollister AS; Oates JA; Robertson D
    J Pharmacol Exp Ther; 1983 Nov; 227(2):484-90. PubMed ID: 6355433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.